Huaxia Ophthalmology (301267.SZ): Net profit of 156 million yuan in the first quarter increased 3.75% year on year

Gelonghui, April 26 | Huaxia Ophthalmology (301267.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 978 million yuan, up 5.09% year on year; net profit attributable to shareholders of listed companies was 156 million yuan, up 3.75% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 157 million yuan, up 6.89% year on year; basic earnings per share were 0.19 yuan.

Gelonghui FinanceApr 25 12:07 ET

Huaxia Ophthalmology (301267.SZ) has repurchased a total of 5.2251 million shares at a cost of 151 million yuan

Huaxia Ophthalmology (301267.SZ) announced that as of February 29, 2024, the company is using centralized bidding transactions...

Zhitong FinanceMar 1 05:54 ET

Returns At Huaxia Eye Hospital GroupLtd (SZSE:301267) Appear To Be Weighed Down

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Typically, we'll want to notice a trend of growing return on capi

Simply Wall StFeb 29 18:27 ET

Huaxia Ophthalmology (301267.SZ) has repurchased a total of 3.788 million shares at a cost of 111 million yuan

Huaxia Ophthalmology (301267.SZ) announced that as of January 31, 2024, the company is using centralized bidding transactions...

Zhitong FinanceFeb 1 05:17 ET

Huaxia Ophthalmology (301267.SZ): We have established long-term and stable cooperative relationships with major ophthalmic medical device manufacturers at home and abroad

Gelonghui January 31 丨 An investor asked Huaxia Ophthalmology (301267.SZ) on the investor interactive platform, “What ophthalmic medical device products has the company laid out?” The company replied that the company has established long-term and stable cooperative relationships with major ophthalmic medical device manufacturers at home and abroad, and has actively introduced cutting-edge international ophthalmology diagnosis and treatment technologies and products to provide comprehensive, diverse and personalized diagnosis and treatment services for patients with eye diseases.

Gelonghui FinanceJan 31 03:39 ET

These 4 Measures Indicate That Huaxia Eye Hospital GroupLtd (SZSE:301267) Is Using Debt Safely

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to co

Simply Wall StJan 23 01:03 ET